Clinical and Developmental Immunology (Jan 2012)

Systemic-Lupus-Erythematosus-Related Acute Pancreatitis: A Cohort from South China

  • Yanlong Yang,
  • Yujin Ye,
  • Liuqin Liang,
  • Tianfu Wu,
  • Zhongping Zhan,
  • Xiuyan Yang,
  • Hanshi Xu

DOI
https://doi.org/10.1155/2012/568564
Journal volume & issue
Vol. 2012

Abstract

Read online

Acute pancreatitis (AP) is a rare but life-threatening complication of SLE. The current study evaluated the clinical characteristics and risk factors for the mortality of patients with SLE-related AP in a cohort of South China. Methods. Inpatient medical records of SLE-related AP were retrospectively reviewed. Results. 27 out of 4053 SLE patients were diagnosed as SLE-related AP, with an overall prevalence of 0.67%, annual incidence of 0.56‰ and mortality of 37.04%. SLE patients with AP presented with higher SLEDAI score (21.70±10.32 versus 16.17±7.51, P=0.03), more organ systems involvement (5.70±1.56 versus 3.96±1.15, P=0.001), and higher mortality (37.04% versus 0, P=0.001), compared to patients without AP. Severe AP (SAP) patients had a significant higher mortality rate compared to mild AP (MAP) (75% versus 21.05%, P=0.014). 16 SLE-related AP patients received intensive GC treatment, 75% of them exhibited favorable prognosis. Conclusion. SLE-related AP is rare but concomitant with high mortality in South Chinese people, especially in those SAP patients. Activity of SLE, multiple-organ systems involvement may attribute to the severity and mortality of AP. Appropriate glucocorticosteroid (GC) treatment leads to better prognosis in majority of SLE patients with AP.